YITEK INTERNATIONAL TRADING CO., LIMITED – Trademark Portfolio

Entity Type: 99

YITEK INTERNATIONAL TRADING CO., LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DR. DYLAN. The owner is based in HK.

ROOM 01 26TH FLOOR WORKING VIEW COMMERCIAL BLDG. 21 YIU WAH STREET CAUSEWAY BAY

HK 999077 , HK

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DR. DYLAN
DR. DYLAN
Registered 2024

Trademark Classifications

YITEK INTERNATIONAL TRADING CO., LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does YITEK INTERNATIONAL TRADING CO., LIMITED have?

YITEK INTERNATIONAL TRADING CO., LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does YITEK INTERNATIONAL TRADING CO., LIMITED file in?

YITEK INTERNATIONAL TRADING CO., LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are YITEK INTERNATIONAL TRADING CO., LIMITED's most well-known trademarks?

YITEK INTERNATIONAL TRADING CO., LIMITED's registered trademark portfolio includes well-known marks such as DR. DYLAN. These are among 1 currently registered trademark in the portfolio.

What is YITEK INTERNATIONAL TRADING CO., LIMITED's trademark registration success rate?

YITEK INTERNATIONAL TRADING CO., LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.